Real-world use of once-weekly semaglutide in patients with type 2 diabetes: results from the SURE Denmark/Sweden multicentre, prospective, observational study
contributed equally to the data interpretation
Patient Centred, Natural Results In Chester From her base in Chester, Cheshire , Miss Breahna cares for patients from the local area, North Wales, and the wider North West
The mechanism by which Semaglutide GLP-1 reduces belly fat is not fully understood, but it may be related to its effects on appetite and satiety, as well as its ability to improve insulin sensitivity and glucose uptake by muscle and fat tissues
The MHRA has reminded clinicians and patients about the small risk of severe acute pancreatitis with GLP-1 and dual GLP-1/GIP medicines
Saxenda contains the active ingredient liraglutide and was the first GLP-1 agonist to be approved by the FDA for the treatment of obesity